LeMaitre Vascular and MicroVision Announce August 2026 Investor Events

LeMaitre Vascular, Inc. (Nasdaq: LMAT) said its management will meet investors at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The company, which supplies devices and implants for peripheral vascular disease, will present its strategy and product portfolio in a virtual format.

MicroVision, Inc. (Nasdaq: MVIS) held its second‑quarter 2026 earnings call on August 6, 2026. Chief Executive Officer Glen DeVos and interim Chief Financial Officer Stephen Hrynewich discussed the quarter’s financial and operating results and provided forward‑looking statements about product delivery, market opportunities and cash flow.

Both events are part of the companies’ regular investor‑relations schedules, offering analysts and shareholders insight into performance and outlook.